Adipose-derived regenerative cells for treating liver injury
First Claim
Patent Images
1. A method of treating alcohol-induced liver injury in a patient in need thereof, comprising:
- (a) identifying a patient with alcohol-induced liver injury;
(b) providing a tissue removal system;
(c) removing adipose tissue from a patient using the tissue removal system;
(d) processing at least part of the adipose tissue to obtain a concentrated population of adipose-derived cells comprising stem cells, wherein the concentration of stem cells is at least 0.1% of the adipose-derived cell population, wherein the processing comprisesdisaggregating the adipose tissue to free adipocytes and other cell populations from adipose tissue matrix to obtain a cell suspension;
reducing the presence of free adipocytes in the cell suspension; and
concentrating the cell suspension, to obtain the concentrated population of adipose-derived cells comprising stem cells; and
(e) administering the concentrated population of adipose-derived cells comprising stem cells to the patient with alcohol-induced liver injury.
7 Assignments
0 Petitions
Accused Products
Abstract
Cells present in processed lipoaspirate tissue are used to treat patients. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the stem cells are not exposed to an external environment prior to being administered to a patient. Compositions that are administered to a patient include a mixture of adipose tissue and stem cells so that the composition has a higher concentration of stem cells than when the adipose tissue was removed from the patient.
151 Citations
14 Claims
-
1. A method of treating alcohol-induced liver injury in a patient in need thereof, comprising:
-
(a) identifying a patient with alcohol-induced liver injury; (b) providing a tissue removal system; (c) removing adipose tissue from a patient using the tissue removal system; (d) processing at least part of the adipose tissue to obtain a concentrated population of adipose-derived cells comprising stem cells, wherein the concentration of stem cells is at least 0.1% of the adipose-derived cell population, wherein the processing comprises disaggregating the adipose tissue to free adipocytes and other cell populations from adipose tissue matrix to obtain a cell suspension; reducing the presence of free adipocytes in the cell suspension; and concentrating the cell suspension, to obtain the concentrated population of adipose-derived cells comprising stem cells; and (e) administering the concentrated population of adipose-derived cells comprising stem cells to the patient with alcohol-induced liver injury. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
-
Specification